First-drug treatment failures in children with typical absence epilepsy

Faruk Incecik1, Sakir Altunbasak1, Ozlem M Herguner1

  • 1Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Cukurova University, Adana, Turkey.

Brain & Development
|June 21, 2014
PubMed

Insights

Photoconvulsive EEG response is a key predictor of treatment failure in childhood absence epilepsy (CAE). Understanding these factors helps optimize antiepileptic drug (AED) selection for better outcomes.

Area of Science:

  • Pediatric Neurology
  • Epileptology

Background:

  • Childhood absence epilepsy (CAE) is a common epilepsy syndrome in children.
  • Characterized by frequent typical absence seizures.
  • Typically responds well to initial antiepileptic drug (AED) monotherapy.

Purpose of the Study:

  • To identify risk factors for initial antiepileptic drug (AED) treatment failure in children with CAE.
  • To improve treatment strategies for pediatric epilepsy.

Main Methods:

  • Survival analysis of predictive factors in 52 children diagnosed with CAE.
  • Univariate and multivariate analyses were performed.

Main Results:

  • The study included 52 children (61.5% girls), with a mean age of seizure onset at 6.5 years.
  • 80.8% of patients responded to the first AED (Group A), while 19.2% did not (Group B).
  • Univariate analysis identified age of seizure onset, coexisting seizure types, and photoconvulsive EEG response as significant predictors of failure. Multivariate analysis confirmed photoconvulsive EEG response as the sole significant risk factor.

Conclusions:

  • Photoconvulsive EEG response is a significant predictor of poor response to initial AED treatment in children with CAE.
  • Age of seizure onset and coexisting seizure types also showed associations in univariate analysis.
  • Identifying these factors can guide more personalized and effective epilepsy management.
Abstract

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.3K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.7K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K